Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Z. G. Laoutidis"'
Autor:
Z. G. Laoutidis, K. T. Kioulos
Publikováno v:
Pharmacopsychiatry. 48:187-199
Desvenlafaxine, the active metabolite of venlafaxine, was approved in 2008 by the FDA for the treatment of depression. The aim of the present review is to provide an overview of the existing trials with desvenlafaxine and assess its overall efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1203f76f3d7e485ccfe535b775ebe351
https://doi.org/10.1055/s-0035-1555879
https://doi.org/10.1055/s-0035-1555879
Autor:
Joachim Cordes, J. Mobascher, Anastasios Konstantinidis, Christian Luckhaus, Renate Grohmann, Z. G. Laoutidis
Publikováno v:
Pharmacopsychiatry. 48(4-5)
The elevation of creatine kinase (CK) levels without neuroleptic malignant syndrome has been reported for several antipsychotics. We present here 4 cases with CK elevation induced by amisulpride, which have been registered for the German pharmacovigi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30488ecc690ba827aef5dc81846bfc4a
https://pubmed.ncbi.nlm.nih.gov/25984709
https://pubmed.ncbi.nlm.nih.gov/25984709
Autor:
Annette Durst, Stelios Orfanos, Wolfram Karges, Ute Habel, Sebastian Vocke, Timur Toygar, Mark Berthold-Losleben, Z. G. Laoutidis, Natalya Chechko, Nils Kohn, Frank Schneider, C. Weidenfeld
Publikováno v:
Europe PubMed Central
Glucose is the primary source of energy for the human brain. Previous literature has shown that varying blood glucose levels may have a strong impact on behaviour, subjective mood, and the intensity of the BOLD signal measured in fMRI. Therefore, blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b4ad5b1b6d84a251608a2cd9125925
http://europepmc.org/abstract/med/25795339
http://europepmc.org/abstract/med/25795339
